Impact of different Sofosbuvir-based direct acting antiviral (DAA) regimen in elderly cirrhotic patients: A real world experience from CLEO Group. (10th February 2016) - Pellicelli, A.M.; Pace Palitti, V.; Vignally, P.; Moretti, A.; Tarquini, P.; Scifo, G.; Messina, V.; Ascione, A.; Izzi, A.; D'Ambrosio, C.; Villani, R.; Fondacaro, L.; et al.